Tooru PLC (AIM:TOO, FRA:73N), the AIM-listed health and wellness group, says its operating businesses generated average monthly gross revenue of around £1 million and EBITDA of £150,000 in the first quarter of 2026, with the board expecting those levels to increase through the year.
The company, whose portfolio includes free-from food brands Juvela, OAF and Pulsin, said it expects its subsidiaries to deliver a strong EBITDA performance for the 2025 financial year compared to the prior period, in line with management expectations.
OAF, which the board views as a key near-term growth driver, has launched with Asda, with initial sales tracking ahead of expectations.
The brand is also introducing new product lines into Tesco, including a range of Softie Sub Rolls, and recently attended the Allergy and Free From Show in Birmingham to build consumer and retail awareness.
Pulsin has returned to growth with improved margins after a period of consolidation and range optimisation, supported by new capital investment and a new contract manufacturing arrangement.
The company said Pulsin maintains strong shelf availability across its key retail channels and is well-positioned for further expansion.
Tooru is also progressing the potential acquisition of Mylky, a business it describes as having strong cash generation characteristics, and is exploring debt funding structures to complete the deal.
The proposed transaction includes the issue of Tooru shares at 0.77 pence, a significant premium to the current share price of 0.19 pence, which the board said better reflects the intrinsic valuation of the business.
The company acknowledged that the current share price reflects broader geopolitical uncertainty that has weighed on investor appetite for growth stocks.
The board said it believes the Mylky acquisition has the potential to add significant scale and earnings capability to the group.
Scott Livingston, chief executive, said the group is "seeing encouraging momentum" with "strong EBITDA delivery, growing revenues and excellent progress from both Juvela and OAF".
He added that Tooru is "well positioned to accelerate growth and continue building value across the portfolio" as it progresses through 2026.